Slayback Pharma announces investment of $50 million by The Everstone Group
The new capital will be used to expand and accelerate further Slayback’s pipeline of complex generic and specialty pharmaceutical…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.